Sunnyvale, CA, United States of America

Shaoling Li

USPTO Granted Patents = 5 

 

 

Average Co-Inventor Count = 5.1

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2008-2022

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Inventor Profile: Shaoling Li

Introduction

Shaoling Li is an innovative inventor based in Sunnyvale, California. He has made significant contributions to the field of pharmaceutical sciences, particularly in developing combination dosage forms.

Latest Patents

Shaoling Li holds a total of five patents to his name. His latest inventions include a cutting-edge combination dosage form of a mu opioid receptor antagonist and an opioid agent. This invention delivers a solid composition of the peripheral mu opioid antagonist axelopran and combines it with an opioid analgesic agent, which may be formulated in various release forms such as extended release, sustained release, modified release, or controlled release. The methods for preparing this combination dosage form promise to enhance pain management therapies.

Career Highlights

Throughout his career, Shaoling Li has worked with notable organizations including Theravance Biopharma R&D IP, LLC, and Nanjing University. His positions at these institutions have allowed him to leverage his expertise in pharmaceutical research and develop innovative solutions that address pain relief.

Collaborations

Shaoling Li has collaborated with several professionals in his field, including coworkers Manshiu Leung and Hao Zhang. These collaborations reflect a strong network of innovators and researchers dedicated to advancing pharmaceutical science.

Conclusion

Shaoling Li's contributions to the field through his patents and collaborative efforts underscore his commitment to innovation in pharmaceutical development. His work continues to shape the way pain management therapies are formulated, making a significant impact on healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…